Summary: In order to ensure optimal management of febrile neutropenia throughout Asia, the IDSA guidelines should be supplemented with local Asian susceptibility and resistance data. In addition, it would be useful to clarify the relative prevalence of bacterial, fungal and viral infections in patients with febrile neutropenia in Asia.